Core Insights - Fulejia showcased its advanced skincare technology and innovative products at the 5th China International Consumer Products Expo, emphasizing its commitment to high-end medical skincare and global brand expansion [1] - The global launch of Sculptra, an injectable poly-L-lactic acid filler, in China marks a significant milestone, as it is the first of its kind approved by both the FDA and the EU, with over 25 years of safety and clinical evidence [1] Industry Summary - The skincare industry is evolving towards more technological and professional solutions, driven by increasing consumer demand for safe and effective products [2] - The market is expected to see strong growth from companies with comprehensive brand matrices and product categories, such as Marubi Biotechnology [2] - Companies like Juzi Biotechnology are poised for rapid development by accurately targeting niche markets, particularly with the rise of collagen reorganization and domestic beauty trends [2] - Betaini is leveraging high cost-performance and strong product innovation to capture market share [2] - Longzi Co. is focusing on both external expansion and internal growth strategies in the medical aesthetics sector, indicating significant future potential [2] - East China Pharmaceutical is demonstrating strong development potential through its innovative drug research and medical aesthetics product pipeline [2]
美容护理行业周报：敷尔佳亮相消博会 关注高效护肤产品需求